Trade and other receivables |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Trade and other receivables | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Trade and other receivables | 14Trade and other receivables
Included within R&D tax relief receivable £8,686 thousand claimed under the HMRC RDEC scheme (2023: £578 thousand) and £nil for R&D tax relief claimed under the HMRC SME Scheme (2023: £15,838 thousand). Expected credit losses were not significant in 2024 or 2023. The Group's exposure to credit and market risks, including impairments and allowances for credit losses, relating to trade and other receivables is disclosed in note 25 Financial risk management and impairment of financial assets. |